AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Does Nirma want to be a pharma company?
Finshots Daily
Nirma's Story: From a Washing Pot of Brand to a Cement Giant
2min Snip
00:00
Summary
Transcript
Episode notes
Nirma has bought Glenmark life sciences. Glenmarks made quite a name for itself in the active pharmaceutical ingredient space Or API business. India is heavily dependent on China for APIs We import 70-80% of our requirements And the government wants domestic Fama to get into the API game fully. If Nirma gets its hands on Glenmark's API business it could finally realise its Fama ambitions. It might be able to snag these incentives and bring down the prices of drugs too.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode